Bristol Myers Squibb was among the investors in a series B round announced alongside a collaboration with the small molecule drug developer.

Prosus co-led the restaurant management software provider’s latest round, which will support its international expansion.

Accenture, Workday and Bank of America helped VR training technology developer Strivr expand its latest round to $65m while Consensys backed a $50m round for blockchain analytics provider Flipside Crypto.

The gene-editing technology developer received further support from SoftBank Vision Fund 2 to advance its genomics drug discovery platform.

SoftBank’s Latin America Fund took part in the biometric security technology developer's latest round, which valued it at $2.6bn.

Citi Ventures, Salesforce Ventures and Telstra Ventures all invested in blockchain infrastructure provider Blockdaemon's series D round while GV backed cybersecurity software provider Obsidian's $90m series C.

Swiggy helped boost the ride hailing service's valuation to $800m in a round that included Shell Ventures and TVS Motor Company.

Coinbase Ventures helped the cryptocurrency exchange increase its valuation to $2.15bn in a round pushing its overall funding past $240m.

Takeda and Bristol Myers Squibb were among the investors that helped the cellular medicine developer close its series B round.

The logistics services provider has added $50m to its latest round, which is already backed by SoftBank, Emtek, Oko Markets and EV Growth.